Day: September 3, 2024

HANOVER, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces that management will be participating in the following investor and industry conferences during the month of September:H.C. Wainwright 26th Annual Global Investment Conference, September 9-11, 2024, at the Lotte New York Palace Hotel. Management will be holding one-on-one meetings with investors and will deliver a company presentation. The recorded presentation will be available on demand beginning Monday, September 9th at 7:00am Eastern time on the Investors section of Processa’s website and here. European Society for Medical Oncology (ESMO) Congress 2024, September 13-17, 2024, in Barcelona. Management will be holding meetings with clinicians, researchers, industry key opinion leaders and potential partners.About Processa Pharmaceuticals,...

UTRECHT, The Netherlands and PHILADELPHIA, Sept. 03, 2024 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, today announced that Stephen Hurly, Chief Executive Officer of LAVA Therapeutics, will present at the H.C. Wainwright 26th Annual Global Investment Conference. Presentation DetailsFormat: Fireside ChatDate: Monday, September 9, 2024Time: 3:30 PM ET A webcast of the presentation can be accessed under the “Events” tab on the investor relations section of the LAVA Therapeutics website at https://ir.lavatherapeutics.com/news-events/events. The replay will be archived for 90 days following the presentation date. About LAVA Therapeutics LAVA Therapeutics N.V. is...

EMERYVILLE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced that management will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference. Members of the management team will also be available for one-on-one meetings. 2024 Cantor Global Healthcare ConferencePresentation Date: Thursday, September 19, 2024Presentation Time: 8:35 a.m. ETWebcast Link: WebcastAn archived copy of the webcast will be available for up to one year by visiting the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events. About 4DMT 4DMT is a leading clinical-stage genetic medicines...

RIDGEFIELD, Conn., Sept. 03, 2024 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (the “Company”) (Nasdaq: CHEF), a premier distributor of specialty food products in the United States, the Middle East and Canada, today announced that the Company will participate in a virtual fireside chat at CL King’s 22nd Best Ideas Conference on Monday, September 16, 2024. The fireside chat will begin at 8:45 a.m. ET. Investors and interested parties may listen to a webcast of the fireside chat by visiting the Company’s investor relations website at http://investors.chefswarehouse.com/. About The Chefs’ Warehouse The Chefs’ Warehouse, Inc. (http://www.chefswarehouse.com) is a premier distributor of specialty food products in the United States, the Middle East and Canada focused on serving the specific needs of chefs who own and/or operate some...

PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech will present at the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9-11, 2024 in New York City. Details of the presentation are as follows: H.C. Wainwright 26th Annual Global Investment ConferenceDate: Tuesday, September 10, 2024 Event: PresentationTime: 2:00-2:30 PM ET To register for the in-person event, please click here. The presentation will be available for on-demand viewing starting on September 10, 2024, at 2:00...

PHILADELPHIA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial and specialty waste streams, today announced that Company management will be participating in the following upcoming investor conferences:Jefferies Industrial Conference (New York, NY)Wednesday, September 4, 2024 Lake Street: 2024 BIG8 Conference (New York, NY)Thursday, September 12, 2024About Enviri Enviri is transforming the world to green, as a trusted global leader in providing a broad range of environmental services and related innovative solutions. The Company serves a diverse customer base by offering critical recycle and reuse solutions for their waste streams, enabling customers to address their most complex environmental challenges and to achieve their sustainability...

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on Monday, September 9, 2024 at 1:30 pm ET. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived for a limited time following the presentation. About Protara Therapeutics, Inc. Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational...

Centralizing all programmatic deals through Magnite provides advertisers with more efficient access to Blitz’s diverse audience NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Blitz, a premier analytics platform offering real-time insights, stats, and improvement tools for gamers, has selected Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, as its preferred SSP. This builds on a successful partnership that has seen Blitz’s gross revenue grow triple-digit percent on Magnite’s DV+ SSP in the first half of 2024. Blitz is concentrating all programmatic deals through Magnite to offer advertisers easier access to the company’s omnichannel inventory including display and video. Blitz offers a dedicated activity-tracking platform used by millions of engaged gamers worldwide, including in the US, Canada, UK, Australia,...